{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:45:46Z","timestamp":1741311946868,"version":"3.38.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,7,10]],"date-time":"2011-07-10T00:00:00Z","timestamp":1310256000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Cardiol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s00246-011-0041-6","type":"journal-article","created":{"date-parts":[[2011,7,9]],"date-time":"2011-07-09T11:27:07Z","timestamp":1310210827000},"page":"1012-1016","source":"Crossref","is-referenced-by-count":4,"title":["Treatment of Acute Heart Failure Using Levosimendan for a Patient With Dilated Cardiomyopathy, Chronic Renal Failure, and Hypertension"],"prefix":"10.1007","volume":"32","author":[{"given":"Pablo","family":"Lobo Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Oulego Erroz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Gautreux Minaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis Miguel","family":"Rodr\u00edguez Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,10]]},"reference":[{"key":"41_CR1","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.ejheart.2005.02.002","volume":"7","author":"C Avgeropoulou","year":"2005","unstructured":"Avgeropoulou C, Andreadou I, Markantosis S (2005) The calcium sensitizer levosimendan improves oxidative damage, BNP and preinflamatory cytokine levels in patients with advanced descompensated heart failure in comparison to dobutamine. Eur J Heart Fail 7:882\u2013887","journal-title":"Eur J Heart Fail"},{"key":"41_CR2","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/eurheartj\/ehi875","volume":"27","author":"L Luca De","year":"2006","unstructured":"De Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M (2006) Evidence-based use of levosimendan in different clinical settings. Eur Heart J 27:1908\u20131920","journal-title":"Eur Heart J"},{"key":"41_CR3","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1007\/s00246-009-9571-6","volume":"31","author":"L Di Chiara","year":"2010","unstructured":"Di Chiara L, Ricci Z, Garisto C, Morelli S, Giorni C, Vitale V, Di Donato RM, Picardo S (2010) Initial experience with levosimendan infusion for preoperative management of hypoplastic left heart syndrome. Pediatr Cardiol 31:166\u2013167","journal-title":"Pediatr Cardiol"},{"key":"41_CR4","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(02)09455-2","volume":"360","author":"F Follath","year":"2002","unstructured":"Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Hariola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L (2002) Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196\u2013202","journal-title":"Lancet"},{"key":"41_CR5","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/CIRCULATIONAHA.106.668640","volume":"115","author":"MM Givertz","year":"2007","unstructured":"Givertz MM, Andreou C, Conrad CH, Colucci WS (2007) Direct myocardial effects of levosimendan in humans with left ventricular dysfunction: alteration of force-frequency and relaxation-frequency relationships. Circulation 115:1218\u20131224","journal-title":"Circulation"},{"key":"41_CR6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1161\/01.CIR.0000043245.00859.11","volume":"107","author":"M Kivikko","year":"2003","unstructured":"Kivikko M, Lehtonen L, Colucci WS (2003) Sustained hemodynamic effects of intravenous levosimendan. Circulation 107:81\u201386","journal-title":"Circulation"},{"key":"41_CR7","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1001\/jama.297.17.1883","volume":"297","author":"A Mebazaa","year":"2007","unstructured":"Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Poder P, Kivikko M (2007) Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial. JAMA 297:1883\u20131891","journal-title":"JAMA"},{"key":"41_CR8","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0735-1097(00)00961-X","volume":"36","author":"MS Nieminen","year":"2000","unstructured":"Nieminen MS, Akkila J, Hasenfuss G, Kleber FX, Lehtonen LA, Mitrovic V, Nyquist O, Remme WJ (2000) Hemodynamic and neurohumoral effects of continuous infusion of levosimendan in patients with congestive heart failure. J Am Coll Cardiol 36:1903\u20131912","journal-title":"J Am Coll Cardiol"},{"key":"41_CR9","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1056\/NEJM199307153290310","volume":"323","author":"M Packer","year":"1993","unstructured":"Packer M (1993) The search for the ideal positive inotropico agent. N Engl J Med 323:201\u2013202","journal-title":"N Engl J Med"},{"key":"41_CR10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/01.CIR.102.18.2222","volume":"102","author":"MT Slawsky","year":"2000","unstructured":"Slawsky MT, Colucci WS, Gottlieb SS, Greenberg BH, Haeusslein E, Hare J, Leier CV, LeJemtel TH, Loh E, Nicklas J, Ogilby D, Singh BN, Smith W (2000) Acute hemodynamic and clinical effects of levosimendan in patients with severe heart failure. Circulation 102:2222\u20132227","journal-title":"Circulation"},{"key":"41_CR11","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1067\/mcp.2000.110972","volume":"68","author":"H Ukkonen","year":"2000","unstructured":"Ukkonen H, Saraste M, Akkila J, Knuuti J, Karanko M, Iida H, Lehikoinen P, N\u00e5gren K, Lehtonen L, Voipio-Pulkki LM (2000) Myocardial efficiency during levosimendan infusion in congestive heart failure. Clin Pharmacol Ther 68:522\u2013531","journal-title":"Clin Pharmacol Ther"},{"key":"41_CR12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(24)36997-6","volume":"283","author":"H Yokoshiki","year":"1997","unstructured":"Yokoshiki H, Katsube Y, Sunagawa M, Sperelakis N (1997) The novel calcium sensitizer levosimendan activates the ATP sensitive K+ channel in rat ventricular cells. J Pharmacol Exp Ther 283:375\u2013383","journal-title":"J Pharmacol Exp Ther"}],"container-title":["Pediatric Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-011-0041-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00246-011-0041-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00246-011-0041-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T01:07:19Z","timestamp":1741309639000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00246-011-0041-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,10]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["41"],"URL":"https:\/\/doi.org\/10.1007\/s00246-011-0041-6","relation":{},"ISSN":["0172-0643","1432-1971"],"issn-type":[{"type":"print","value":"0172-0643"},{"type":"electronic","value":"1432-1971"}],"subject":[],"published":{"date-parts":[[2011,7,10]]}}}